APOLLO MEDICAL Reports Record Q2 Earnings of USD 348.2 Million and Net Income USD 13.2 Million, Up 29.1% and 15.5%, Respectively
August 21, 2023
☀️Earnings Overview
APOLLO MEDICAL ($NASDAQ:AMEH) has announced that their earnings for the 2023 fiscal year, which ended on June 30th, totaled USD 348.2 million in revenue – a 29.1% increase from the previous year – and net income of USD 13.2 million, a 15.5% rise from the year prior.
Analysis
GoodWhale has conducted an in-depth analysis of APOLLO MEDICAL‘s wellbeing. According to their Risk Rating, APOLLO MEDICAL is a high risk investment in terms of financial and business aspects. GoodWhale has detected three risk warnings in the company’s income sheet, balance sheet, and non-financial data. For more information, customers are invited to register on goodwhale.com to verify the analysis and receive further insights. More…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Apollo Medical. More…
| Total Revenues | Net Income | Net Margin |
| 1.3k | 49.69 | 4.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Apollo Medical. More…
| Operations | Investing | Financing |
| 65.81 | -7.11 | -20.09 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Apollo Medical. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 1.03k | 442.9 | 12.16 |
Key Ratios Snapshot
Some of the financial key ratios for Apollo Medical are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 24.9% | 40.7% | 8.8% |
| FCF Margin | ROE | ROA |
| 3.5% | 12.7% | 7.0% |
Peers
The healthcare industry is highly competitive, with Apollo Medical Holdings Inc competing against some of the largest companies in the world.
However, Apollo has been able to maintain a strong position in the industry through its innovative products and services. The company has a strong focus on research and development, which has allowed it to bring new and innovative products to market. Additionally, Apollo has a strong marketing and sales force that has helped it to gain market share.
– HealthCare Global Enterprises Ltd ($BSE:539787)
HealthCare Global Enterprises Ltd has a market cap of 41.71B as of 2022, a Return on Equity of 13.62%. The company is a leading provider of healthcare services in India with a network of over 30 hospitals across the country. The company offers a comprehensive range of services including medical and surgical care, diagnostics, and preventive healthcare.
– Cano Health Inc ($NYSE:CANO)
Cano Health Inc is a healthcare services company that operates primary care and specialty care clinics in the United States. The company has a market cap of 828.58M as of 2022 and a Return on Equity of -2.88%. Cano Health Inc provides healthcare services to patients through its network of primary care and specialty care clinics. The company offers a range of services including primary care, specialty care, and behavioral health services. Cano Health Inc also provides pharmacy services and operates a laboratory.
– Dhanvantri Jeevan Rekha Ltd ($BSE:531043)
Dhanvantri Jeevan Rekha Ltd is a publicly traded company with a market cap of 64.14M as of 2022. The company’s Return on Equity is 3.31%. Dhanvantri Jeevan Rekha Ltd is engaged in the business of providing healthcare services in India. The company offers a wide range of services including medical consultation, diagnostics, surgery, and other treatments.
Summary
APOLLO MEDICAL has experienced steady growth over the last fiscal year, with total revenue increasing 29.1% and net income growing 15.5%. This is an attractive investment opportunity for investors looking for a well-performing company. The company has seen strong gains in both revenue and profits and has a highly competitive market position. With strong balance sheets and management teams, as well as attractive valuations, APOLLO MEDICAL is well positioned to continue to demonstrate strong growth going forward.
Related Posts
Recent Posts
